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ABSTRACT
DNA decatenation mediated by Topoisomerase II is
required to separate the interlinked sister chroma-
tids post-replication. SGS1, a yeast homolog of the
human RecQ family of helicases interacts with
Topoisomerase II and plays a role in chromosome
segregation, but this functional interaction has
yet to be identified in higher organisms. Here, we
report a physical and functional interaction of
Topoisomerase IIa with RECQL5, one of five mam-
malian RecQ helicases, during DNA replication.
Direct interaction of RECQL5 with Topoisomerase
IIa stimulates the decatenation activity of
Topoisomerase IIa. Consistent with these observa-
tions, RECQL5 co-localizes with Topoisomerase IIa
during S-phase of the cell cycle. Moreover, cells
with stable depletions of RECQL5 display a slow
proliferation rate, a G2/M cell cycle arrest and late
S-phase cycling defects. Metaphase spreads gene-
rated from RECQL5-depleted cells exhibit under-
condensed and entangled chromosomes. Further,
RECQL5-depleted cells activate a G2/M checkpoint
and undergo apoptosis. These phenotypes are
similar to those observed when Topoisomerase II
catalytic activity is inhibited. These results reveal
an important role for RECQL5 in the maintenance
of genomic stability and a new insight into the
decatenation process.
INTRODUCTION
The RecQ family of helicases has been called the ‘guard-
ians of the genome’ because they play critical roles in
maintaining genome integrity. In general, the loss of
function of RecQ helicases is thought to increase the
mutational load in the cell. Mutations in at least three
of the ﬁve RecQ helicases, Werner (WRN), Bloom
(BLM) and RECQL4 in humans give rise to segmental
premature aging phenotypes and cancer predisposition
(1). RecQ helicases are characterized by the presence of
a DExH and a RecQ-Ct domain (2). RECQL5 is one of
the least characterized human RecQ helicases with a
C-terminal region that shares no homology with the
other family members. There are at least three different
isoforms of RECQL5 resulting from alternative RNA
splicing. The largest splice variant, RECQL5b (hereafter
referred to as RECQL5), localizes to the nucleus and
possesses DNA helicase activity (3,4). It has also been
shown to harbor an intrinsic strand annealing activity,
strand exchange activity and promote branch migration
of Holliday junctions (5).
RECQL5 interacts with the MRN complex,
Topoisomerase IIIa and b and RNA polymerase II
(4,6–8). RECQL5s role in replication has been docu-
mented by its co-localization to PCNA during S-phase
after hydroxyurea (HU) and UV stress (9). Work from
our laboratory demonstrated that RECQL5 interacts
with FEN1 and stimulates FEN1 cleavage activity on a
variety of DNA substrates that are proposed intermediates
in DNA replication (10). Further Recql5 knockout mouse
embryonic ﬁbroblasts are sensitive to camptothecin and to
thymidine-induced replication stress (11,12). Evidence for
a role in homologous recombination (HR) comes from
studies in knockout mice where RECQL5 displaced
Rad51 from single strand DNA and disrupted Rad51
presynaptic ﬁlament formation (13). Recql5 knockout
mice are also highly cancer prone and the embryonic
ﬁbroblasts cells display elevated levels of sister chromatid
exchanges (SCE) (13,14). Interestingly, loss of RecQ5
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recent work demonstrated that lack of RecQ5 in
Drosophila syncytial embryos induced the formation of
anaphase bridges (15,16).
Segregation of intertwined chromosomes immediately
after replication along with condensation of chromo-
somes and centromere separation requires the activity of
a type II topoisomerase. Topoisomerase IIa is a highly
conserved nuclear enzyme which plays a role in relieving
topological stress in cells. It catalyzes the transient
breaking of both strands of a duplex DNA, which then
allows another intact duplex to pass through the break,
and rejoining of two strands of cut duplex DNA, thus
altering the topology of DNA (17). Topoisomerase IIa is
the molecular target for many clinically useful
anti-neoplastic drugs (18,19). Studies have also implicated
Topoisomerase IIa as a potential prognostic marker in
tumors (20–22).
Interestingly, SGS1, the RecQ homolog in yeast, inter-
acts with Topoisomerase II to faithfully segregate chromo-
somes (23). Though BLM interacts with Topoisomerase
IIa, no mammalian RecQ helicase has been shown to
inﬂuence the decatenation activity of Topoisomerase IIa
(24). In this report, we demonstrate the interaction
between RECQL5 and Topoisomerase IIa that serves to
stimulate the decatenation of DNA by Topoisomerase IIa
and we show the co-localization of the two proteins during
late S-phase. We describe a Topoisomerase IIa dysfunc-
tion in RECQL5-depleted cells, leading to a modest G2/M
arrest and the formation of undercondensed and
entangled chromosomes. We show that the stimulation
of Topoisomerase IIa decatenation activity is RECQL5
speciﬁc; thus identifying RECQL5 as a functional
homolog of yeast SGS1. Further, RECQL5 depletion in
cells leads to increased apoptosis. Based on this work, we




HeLa, U2OS, WI38 and HCT116 were purchased from
ATCC and grown according to ATCC protocols. HEK
293T (ATCC) used for generating lentivirus was cultured
in DMEM media supplemented with 10% Hyclone
characterized FBS.
Generation of lentivirus and stable knockdown cells
pLKO.1 vector harboring shRNA constructs targeting
human Recql5 was obtained from Sigma Aldrich.





TG-30 targeting the CDS. shRNA construct expressing
scrambled sequence was purchased from Addgene
(Deposited by the Sabatini lab). Second-generation
VSV-G pseudotyped lentiviruses were generated by
transient co-transfection of HEK 293T cells with a
three-plasmid combination. Brieﬂy, one 50–60% conﬂuent
10cm dish with 293T cells was transfected using FuGENE
6 (Roche) with 5mg lentiviral vector, 2.5mg pCMV R8.2
(Addgene, deposited by the Weinberg lab) and 2.5mg
pCMV VSV-G (Addgene, deposited by the Weinberg
lab). Supernatants were collected 48h after transfection,
pooled, ﬁltered through a 0.45-mm ﬁlter, ﬂash frozen and
stored at  80 C. For lentiviral transduction, 2  10
5 cells
were seeded in 10cm culture plates and transduced the
following day with appropriate lentivirus. Forty-eight
hours post transduction, the cells were split and selected
with puromycin at 2mg/ml. The cells were maintained in
selection media.
RECQL5 antibody generation
A fragment of Recql5 gene corresponding to amino acids
813–963 was PCR ampliﬁed and cloned into pTXB1
plasmid (New England Biolabs). The resulting construct
was sequenced and transformed into BL21(DE3)
CodonPlus RIPL Escherichia coli strain (Stratagene).
Bacteria were grown to OD600= 0.7 in LB medium sup-
plemented with 100mg/ml ampicillin and 50mg/ml chlor-
amphenicol. Protein expression was induced with 0.2mM
IPTG for 3h at 37 C. Cells were collected and protein
puriﬁcation performed on chitin resin (New England
Biolabs) according to manufacturer’s instructions.
Puriﬁed C-terminal fragment of RECQL5 was sent to
Convance Inc. (Denver, PA, USA) for polyclonal antibody
production in rabbits. Antibodies were afﬁnity-puriﬁed
using AminoLink Plus Immobilization Kit (Thermo
Scientiﬁc).
Growth assays
Scrambled or RECQL5 knockdowns were counted and
plated 96h after transduction and 48h post selection
into eighteen dishes, 10
4 cells/dish. Three dishes were har-
vested every 24-h post plating and counted using a Coulter
counter. The ﬁrst set of three harvested on Day 1 were
used to normalize as plating controls.
Flow cytometry
To measure cell cycle status, cells were harvested by
trypsinization, and were combined with the media from
the cell cultures containing ﬂoating (mitotic) cells to
ensure that the analysis was not biased by excluding
M-phase events. After a brief centrifugation, the cell pellets
were resuspended in 0.5ml of FBS and frozen at  70 C.
They were stained for cell cycle analysis using the
Nuclear Isolation Medium (NIM) procedure (25).
This detergent-based one-step method [50mg/ml
propidium iodide (PI) in the presence of RNAse]
produces nuclei that have DNA histograms with tight
CVs (<1% for lymphocytes), thus yielding more precise
cell cycle measurements. The percentage of cells in the
G0/G1, S and G2+M phases of the cell cycle were
deconvoluted using Multicycle Software (Phoenix Flow
Systems, San Diego, CA, USA) and corrected for the
effects of debris and doublets by software algorithms
(25,26).
1622 Nucleic Acids Research, 2012,Vol.40, No. 4To quantitate the percentage of cells directly undergo-
ing DNA synthesis (S-phase), cells were exposed to freshly
made 10mM 5-bromodeoxyuridine (BrdU; Sigma
Chemical Co., St Louis, MO, USA) for 30min, harvested
by centrifugation at 4 C, washed twice with cold
phosphate-buffered saline (PBS), ﬁxed with 10ml of cold
70% ethanol at  20 C and stored at this temperature
until analysis. For bivariate analysis of BrdU incorpor-
ation across the cell cycle, ﬁxed cells were processed fol-
lowing the procedure described by Donahue et al. (27) in
which pepsin and acid treatments are used for high reso-
lution BrdU analysis. Incorporated BrdU was detected
using a ﬂuorescein (FITC)-conjugated antibody to BrdU
(clone B44, BD Biosciences, San Jose, CA, USA) and
counterstained with 10mg/ml PI before ﬂow cytometric
analysis. Histograms consisting of 25000–50000 cells
were acquired on a LSRII (BD Biosciences). In some
experiments, cells were incubated with 10mM BrdU for
24h. This procedure provides a dynamic approach to
access cell division history across one cell cycle (27).
Notably the absence of daughter G0/1 cells with dimin-
ished BrdU content indicates either diminished time to
traverse the cell cycle or block which can be identiﬁed
on the basis of DNA content and also provides an
estimate of the number of quiescent cells in non-G1
phase compartments (i.e. those that fail to take up BrdU
in a 24-h time period).
Metaphase spreads and telomeric FISH
RECQL5 depleted and scrambled control U20S cells were
treated with 200ml of 0.5% colcemid for 3h. Cells were
then harvested and immediately incubated in 75mM KCl
for 20min in 37 C, followed by ﬁxation in ice-cold (3:1)
methanol and glacial acetic acid. Metaphase spreads were
then made by dropping the cells onto a glass slide. The
spreads were stained using 4,6-diamidino-2-phenylindole
(DAPI) as described previously (28). For telomeric FISH,
metaphase spreads generated above were hybridized with
a Cy3-labeled PNA (CCCTAA)3 C-telomere probe
(0.3mg/ml, Panagene) and counterstained with DAPI.
Images were captured using CytovisionTM software
(Applied Imaging Corp.) on a ﬂuorescence microscope
(Axio2; Carl Zeiss, Germany).
Immunoﬂuorescence
Exponentially growing cells were plated on Lab-Tek II
chambered glass slides (Thermo-Fisher Scientiﬁc) and
treated with 2mM HU (Sigma) for 16h or 9mM R03306
for 20h. HU containing media was then replaced by
DMEM and cells were ﬁxed at the time points indicated
in text. Cells were ﬁxed and treated with antibodies as
described previously (29). The following antibodies were
used as described in the ‘Results’ section- Primary:
RECQL5 (1:200, rabbit), Topoisomerase IIa (Santa
Cruz Biotechnology; 1:200, mouse). Secondary: Donkey
anti-rabbit AlexaFluor 488 at 1:1000 dilution and donkey
anti-mouse AlexaFluor 647, 1:1000 dilutions. Images were
captured with Nikon Eclipse TE2000 confocal microscope
and analyzed using Volocity-5 software (PerkinElmer).
Co-localization channels (positive product of the
difference from the mean (PDM) channels) were generated
to highlight the co-localized foci.
DNA decatenation assay
Nuclear extracts were prepared as previously described
(30). Recombinant RECQL5 protein was overproduced
as a fusion protein with an intein–chitin-binding domain
(CBD) self-cleaving afﬁnity tag in E. coli BL21(DE3)
CodonPlus RIPL strain (Stratagene), and puriﬁed as pre-
viously described (31). Recombinant Topoisomerase IIa
was commercially available as a Topoisomerase IIa
assay kit from VAXRON. Kinetoplast DNA (kDNA)
was prepared from Crithidia fasciculata as described
previously (32).
DNA decatenation assays were performed as suggested
by the manufacturer but using C. fasciculata kDNA.
Brieﬂy, varying amounts of nuclear extracts from scram-
bled or RECQL5-depleted cells (0.5, 1.0 and 2.0mg) were
incubated with 100ng of kDNA substrate in 10ml reaction
buffer (50mM Tris–HCl pH 8.0, 100mM NaCl, 10mM
MgCl2, 2mM ATP and 1mM DTT) at 37 C for 15min.
The reactions were terminated by adding SDS and pro-
teinase K and further incubation at 37 C for 30min. The
entire reaction mixtures were separated on 1% agarose gel
containing ethidium bromide (0.5mg/ml). Results were
analyzed by ImageQuant version 5.2 (GE Healthcare).
To examine functional interaction, Topoisomerase IIa
(20fmol) was incubated with recombinant RECQL5
(0.2, 1.0, 2.0, 10, 20fmols). Reaction was performed as
described above.
Decatenation activities of the nuclear extracts were
quantiﬁed by measuring the decatenated kDNA band
intensity, and shown as relative decatenation (100% for
2.0mg of scrambled nuclear extracts). Decatenation
activities of recombinant proteins were quantiﬁed using
the same procedure and shown as relative decatenation
(one for Topoisomerase IIa alone).
Helicase assay
RECQL5 (8fmols) was incubated with 1fmole of a
forked duplex substrate (22-bp with a 30 overhang of
15-bp and labeled on the 50 end) in 20ml reaction buf-
fer containing 20mM Tris pH 7.4, 20mM NaCl, 25mM
KCl, 2.5mM MgCl2, 2.5mM ATP, 1mM DTT, 100mg/ml
BSA and 5% glycerol at 37 C for 20min. Increasing
amounts of Topoisomerase IIa (8, 40, 80fmols) were
added into the reaction mixtures. Reactions were
terminated by addition of 10ml of stop dye (50mM
EDTA, 38% glycerol, 0.9% SDS, 0.05% bromophenol
blue and 0.05% xylene cyanol) and products were
separated on 8% native polyacrylamide gel. Results were
visualized using a Typhoon phosphorimager (GE Health
Sciences) and analyzed by ImageQuant version 5.2
(GE Healthcare).
Western blots
Cells were lysed in RIPA buffer (50mM Tris–HCl pH 8.0,
150mM NaCl, 0.1% SDS and 0.5% sodium deoxy-
cholate) in the presence of protease and phosphatase in-
hibitors (Roche). Protein concentrations of the extracts
Nucleic Acids Research,2012, Vol.40, No. 4 1623were determined using Bradford protein assay kit
(Bio-rad). Thirty or 50mg of total protein from each
sample was applied onto precast 4–12% SDS–
polyacrylamine gel (Invitrogen) and transferred to PVDF
membrane (Invitrogen). The following antibodies were
used: rabbit-anti RECQL5 generated in house, mouse-
anti Topoisomerase IIa (Santa Cruz Biotechnology;
1:1000), mouse-anti PARP1 (Santa Cruz Biotechnology;
1:1000), anti-Chk1 (Santa Cruz Biotechnology; 1:1000),
anti-Chk2 (Santa Cruz Biotechnology; 1:1000),
anti-phospho Chk2 thr 68 (Santa Cruz Biotechnology;
1:1000), anti-phospho ATM ser 1981 (Santa Cruz
Biotechnology; 1:1000), rabbit-anti cleaved PARP1 (Cell
Signaling; 1:1000), anti-phospho Chk1 Ser 345 (Abcam;
1:1000), anti-ATM (Abcam; 1:1000), rabbit anti-lamin A/
C (Sigma; 1:10000) and mouse-anti b-Actin
(Sigma;1:10000).
Quantitative RT–PCR
The extent of lentiviral-mediated Recql5 mRNA reduc-
tion was measured using real-time PCR analysis con-
ducted using RNA extracted from cells 3 days after
infection. cDNA was made from total RNA using
MultiScribe
TM reverse transcriptase (Roche). A commer-
cial TAQMAN
TM probe (Applied Biosystems) for Recql5
(Hs01005415_m1) was used to measure the Recql5 mRNA
transcripts. A probe for the house-keeping gene Gapdh
(Hs00266705_g1) was used as an internal loading
control. All samples were run on a 7900T fast real-time
PCR system (Applied Biosystems).
Immunoprecipitations
Cells were washed in ice-cold PBS and lysed in a lysis
buffer [50mM Tris–HCl (pH 7.4), 150mM NaCl, 1%
Triton X-100, 2mM EDTA] containing Complete
Protease Inhibitor Cocktail Tablets (Roche), 1mM
phenylmethylsulfonyl ﬂuoride (PMSF) and 50mg/ml
ethidium bromide for 30min on ice. The suspension was
centrifuged at 14000g for 20min at 4 C. Lysates were
pre-cleared with 40ml slurry of protein A/G-agarose
beads (Thermo Sciences) for 1h at 4 C. Extracts (500mg
each) were incubated with either 4mg of 0.2mg/ml rabbit
anti-RECQL5, 4mg of rabbit anti-Topoisomerase IIa
antibody (Santa Cruz Biotechnology) or 4mg of rabbit
IgG (Santa Cruz Biotechnology) as a negative control,
overnight at 4 C. Immunocomplex was captured by 80ml
of protein A/G beads slurry for 4h at 4 C, followed
by multiple washes. Bound proteins were eluted from
beads by boiling in 2  reducing loading dye for 5min
and were analyzed by 4–15 % Tris–Glycine SDS-PAGE.
The mouse anti-Topoisomerase IIa antibody (Santa Cruz
Biotechnology; 1:1000), rabbit anti–RECQL5 antibody
(1:1000) generated in house and anti-mouse HRP
conjugated antibody (Amersham; 1:10000) were used in
western Blot analysis following ECL chemiluminescent
analysis (Amersham). For detection of RECQL5
protein, rabbit IgG TrueBlot antibody (eBioscience) was
used.
RESULTS
RECQL5 depletion is associated with slow proliferation
rate, arrest in G2/M phase and late S-phase cycling
defects
In order to characterize the role of RECQL5 in human
cells, RECQL5 was depleted by using lentivirus packaged
with plasmids stably expressing a short hairpin (sh)RNA
targeted to the 30-UTR (shRECQL5-1) or the coding
sequence (shRECQL5-2). Using quantitative PCR, we
measured the Recql5 mRNA and it was reduced by
 50% with the shRECQL5-1 and >70% with the
shRECQL5-2 compared to the control cells (Figure 1A).
Upon reduction of the endogenous RECQL5 protein
levels, the knockdown cells failed to proliferate at the
same rate as their scrambled shRNA counterparts as
evidenced by the size of the colonies formed by these
cells (Figure 1B). RECQL5 protein levels in HeLa cells
were signiﬁcantly reduced after 2 days of selection as
compared to cells transduced with the control
(shScrambled) RNA (Figure 1C). Additionally, measure-
ment of the proliferation rate indicated that by Day 10
post lentiviral transduction, control cells grew nearly
7-fold faster than cells depleted using shRECQL5-1, and
nearly 15-fold faster than cells depleted using
shRECQL5-2 (Figure 1C), suggesting that this phenotype
was dose dependent. Similar results were observed in
WI38 and HCT116 cells stably expressing RECQL5 tar-
geting shRNAs, indicating that the results were not cell
type speciﬁc (Figure 1D and E). The rate of cell doubling
also appeared to correlate, in a dose-dependent manner,
with the RECQL5 expression levels (Figure 1C–E).
To further investigate the cellular proliferation defect
after RECQL5 depletion, cell cycle analysis of asynchron-
ous cultures was performed. Our results indicated that
depletion of RECQL5 caused a modest accumulation of
cells in the G2/M phase of the cell cycle, observed in both
HeLa (Figure 1F) and in WI38 cells (Figure 1G). We also
observed a decrease in G0/G1 phase in RECQL5-depleted
HeLa cells and a decrease in S-phase in RECQL5-depleted
WI38 cells.
Next, we checked for the cycling of the cells during
S-phase using BrdU incorporation, for either 30min or
24h, followed by BrdU content analysis across the
cell cycle. The 30min pulse experiments showed an
expected decrease in the BrdU incorporation in both
HeLa (Figure 2A, 18.4% for control versus 14.6% and
12.6% for RECQL5 shRNA treated) and in HCT116
cells (Figure 2C, 42.2% for control versus 33.9% and
33% for RECQL5 shRNA treated). However, signiﬁcant-
ly noticeable was the decrease in the overall BrdU positive
4N population in the RECQL5 knockdowns, as compared
to the scrambled, suggesting a loss of actively replicating
cells at the 4N stage. This was clearly evidenced in the 24h
pulse (Figure 2B and D), where the 4N populations were
arrested in the ﬁrst cell cycle round in the knockdowns
when compared to the scrambled (compare quantiﬁed
BrdU
+ late S-G2 populations in Figures 2B and 2D).
The RECQL5 knockdown cells ﬁnished duplicating their
DNA, but they were slower to continue through the 4N
stage to the second and subsequent generations.
1624 Nucleic Acids Research, 2012,Vol.40, No. 4Figure 1. RECQL5 depletion is associated with slow proliferation rate, arrest in G2/M phase, and late S-phase cycling defects. (A) Quantitative
RT–PCR analysis of the Recql5 mRNA levels normalized to endogenous GAPDH, in HeLa shScrambled, shRECQL5-1 (n=3) P=0.0006
and shRECQL5-2 (n=3) P=0.0002, Student’s t-test. (B) Methylene blue stained colonies of HeLa shScrambled and HeLa shRECQL5-2.
Growth assays were performed with (C) HeLa, (D) WI38 or (E) HCT116 using shScrambled, shRECQL5-1 and shRECQL5-2 as described
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(continued)Consistent with these observations, the BrdU intensity in
the shScrambled cells was lower than the RECQL5 deﬁ-
cient cells indicating the increased rate of proliferation of
the shScrambled cells because BrdU incorporation is
halved with every cell cycle. Combining these results
with the accumulation of cells at the G2/M phase, we
concluded that RECQL5 deﬁcient cells were slower to
traverse the G2/M cell cycle post-replication.
Stable RECQL5 depletion causes metaphase
chromosome defects
To identify whether RECQL5-depleted cells have a post-
replication defect, we generated metaphase spreads from
U2OS and WI38 cells expressing shRECQL5-2 or
shScrambled RNA. Previous studies in Drosophila have
indicated that loss of RecQ5 leads to mitotic defects
(15). Strikingly, metaphase spreads from RECQL5
knockdown cells generated nearly 5-fold more under-
condensed chromosomes and more than double the num-
ber of entangled chromosomes relative to the scrambled
controls (Figure 3A–C). In order to conﬁrm that our
observation of undercondensed chromosomes was not
due to end-to-end chromosome cohesion, we labeled the
metaphases with a telomeric probe and were able to
identify the chromosomes as separate (Figure 3D).
However, not all the telomeres were labeled and DAPI
staining was diffused. We attributed the absence of some
telomeric signals to the decondensation of DNA, which
could account for the diffused pattern of DAPI staining
(Figure 3D, indicated by the yellow arrows). Similar
results were obtained in WI38 cells after stable depletion
of RECQL5 (Supplementary Table S1).
RECQL5 interacts with Topoisomerase IIa
The aberrant condensation of mitotic chromatids has pre-
viously been described in cells treated with Topoisomerase
II catalytic inhibitors, e.g.: ICRF-193 (33). Additionally, a
depletion of Topoisomerase IIa resulted in accumulation
of cells in G2/M similar to the one we observed after
stable knockdown of RECQL5 (34). Given similar
cellular phenotypes, we hypothesized that depletion of
RECQL5 generates a Topoisomerase IIa dysfunction.
Previously, it has been reported that RECQL5 interacts
with RNA polymerase II and represses transcription (35).
We therefore examined if changes in RECQL5 levels could
result in the modulation of Topoisomerase IIa levels in the
cells. Western blot analysis showed that Topoisomerase
IIa was expressed at a similar level in RECQL5-depleted
and in control cells (Figure 4A). Next, we determined if
there was any physical interaction between RECQL5 and
Topoisomerase IIa. Immunoprecipitation of endogenous
RECQL5 from HeLa cells pulled down Topoisomerase
IIa indicating the presence of RECQL5 and
Topoisomerase IIa in a complex (Figure 4B). Reciprocal
immunoprecipitation of Topoisomerase IIa precipitated
RECQL5 as well (Figure 4C). In order to determine
whether these proteins interact directly, we performed an
in vitro immunoprecipitation of puriﬁed RECQL5 with
puriﬁed Topoisomerase IIa. This experiment
demonstrated the possibility of a direct binding of
Topoisomerase IIa to RECQL5 (Figure 4D).
Since we found that only a small fraction of
Topoisomerase IIa interacted with RECQL5, we next
inquired whether the direct interaction between RECQL5
and Topoisomerase IIa was cell cycle dependent. It has
been previously reported that a type II topoisomerase is
required, among other processes, for replication termin-
ation (17). The expression of Topoisomerase IIa ﬂuctuates
during the cell cycle and peaks during the replicative phase
of growth (36). To examine at what stage of the cell cycle
RECQL5 and Topoisomerase IIa were acting in concert,
we arrested cells in S-phase using a sublethal dose of HU
(37). Cells were then released and the co-localization of
RECQL5 and Topoisomerase IIa was followed by
co-immunoﬂuorescence at the indicated time points
(Figure 4F). A cell cycle proﬁle for each time point was
analyzed (Figure 4E). Immediately after release from HU,
there was low detectable co-localization (as shown by the
intensity of the yellow signal under co-localization-
channel). With increasing time, the co-localization
increased and reached a maximum 2-h post release
(Figure 4F). The observed co-localization across the
nucleus suggests that the two proteins interact around
mid-S-phase when the parental DNA strands are being
duplicated. The interaction persisted through S-phase
and until 4h after HU release. This was further conﬁrmed
by a co-immunoprecipitation experiment, where we
observed increased interaction of Topoisomerase IIa
with RECQL5 as the cells passed through S-phase
(Supplementary Figure 1A and B). These results were con-
sistent with our previous data where we observed a late
S-phase cycling defect that may lead to entangled and
undercondensed chromosomes.
RECQL5 stimulates Topoisomerase IIa decatenation
activity
Topoisomerase IIa is indispensible for the decatenation of
intertwined sister chromatids after replication and before
mitosis (38). Since we identiﬁed a high incidence of
entangled and undercondensed chromosomes in the
Figure 1. Continued
in ‘Materials and Methods’ section. Error bars represent  SD, n=3. The non-linear ﬁt was calculated and R square (Y=Y 0*e
k*X
) values are 0.989
for shScrambled, 0.982 for shRECQL5-1 and 0.7416 for shRECQL5-2 in HeLa, 0.983 for shScrambled, 0.927 for shRECQL5-1 and 0.25 for
shRECQL5-2 for WI38 experiments and 0.995 for shScrambled, 0.993 for shRECQL5-1 and 0.976 for shRECQL5-2 in HCT 116 experiments.
Graphical representation of the doubling time calculated as an average of two independent growth assays. Error bars represent  SD, n=6 for each
sample, each day; ***P<0.0005, **P<0.005, *P<0.05, Student’s t-test. Western blot showing reduced expression of RECQL5 in (C) HeLa,
(D) WI38 or (E) HCT116 whole-cell lysates 96h following transduction with lentivirus harboring shRECQL5-1, shRECQL5-2 RNA compared to
control shScrambled RNA. Equal loading was conﬁrmed by probing with anti-Actin antibody. Quantiﬁcation of PI staining of asynchronous
populations in (F) HeLa and (G) WI38 shScrambled and RECQL5-depleted cells. Error bars represent  SD, n=2; *P=0.0359 between HeLa
shScrambled and sh RECQL5-1 and *P=0.0262 between HeLa shScrambled and shRECQL5-2, Student’s t-test.
1626 Nucleic Acids Research, 2012,Vol.40, No. 4Figure 2. RECQL5 depletion is associated with late S-phase cycling defects. Representative ﬂow cytometry images of (A and B) HeLa and (C and D)
HCT116 scrambled and RECQL5 knockdown cells analyzed for the ability to incorporate bromodeoxyuridine (BrdU) and plotted against DNA
content in (A and C) a 30min BrdU pulse and (B and D) 24h pulse. For panels A and C, the fraction of BrdU positive cells are denoted in the upper
left. The late S-G2 of the BrdU positive cells subpopulation, boxed area, is also quantiﬁed in the upper right. For panels B and D, the ﬁrst generation
slow late S-G2 population is boxed and quantiﬁed.
Nucleic Acids Research,2012, Vol.40, No. 4 1627metaphase spreads of the RECQL5-depleted cells and a
physical interaction between RECQL5 and Topoisomerase
IIa, we tested the possibility that RECQL5 could
modulate the decatenation activity of Topoisomerase
IIa. Comparison of the decatenation activity within
knockdown cells to their scrambled counterparts indicated
that nuclear extracts of HeLa cells depleted of RECQL5
displayed decreased decatenation of kinetoplast DNA
(kDNA) as compared to the scrambled shRNA
treated controls (Figure 5A). To measure decatenation
activity quantitatively, we used varying amounts of
nuclear extracts in the in vitro decatenation assays.
Quantiﬁcation of the relative decatenation revealed that
there is a correlation between the RECQL5 levels and the
decatenation activity of the nuclear extracts (Figure 5B).
Similar results were observed with WI38 (Supplementary
Figure 2A and B) indicating that this is not cell type
dependent. Interestingly, RECQL5 directly stimulated
Topoisomerase IIa catalyzed decatenation of kDNA
in vitro, as evidenced by the increase in the decatenated
DNA band intensity with increasing RECQL5 (Figure 5C
and D). The stimulation was not as profound as the results
observed with the cell extracts. This could be because in a
cellular context, other protein(s) may inﬂuence the activity
along with RECQL5 in a complex or perhaps a
post-translational modiﬁcation in RECQL5 stimulates
its activity.
RECQL5 is a DNA helicase which associates with the
replication machinery and accumulates at sites of stalled
replication forks (6,11). We tested whether Topoisomerase
IIa could inﬂuence the helicase function of RECQL5, and
observed that the presence of Topoisomerase IIa strongly
inhibited the helicase activity of RECQL5 (Figure 5E).
This could be attributed to competition for the DNA sub-
strate. It could also be a mechanism of a functional
co-regulation of the two proteins; in the presence of
Figure 3. Stable RECQL5 depletion causes metaphase chromosome defects. (A) Metaphase spreads of U2OS cells after RECQL5 depletion. Two
observed phenotypes, undercondensation and entanglement of chromosomes, are shown. (B) Quantiﬁcation of metaphase spreads from shScrambled
and shRECQL5-2 depleted U20S cells. Results are an average of two independent biological experiments. A minimum of 50 metaphase spreads per
cell line were analyzed. Error bars represent  SD, *P=0.0349, ***P=0.0006, Student’s t-test (C) Western blot showing reduced expression of
RECQL5 in U2OS whole-cell lysates 96h following transduction with lentivirus harboring shRECQL5-2 RNA compared to shScrambled RNA.
Equal loading was conﬁrmed by probing with anti-Actin antibody. (D) Fluorescence in situ hybridization in metaphase spreads of U2OS
shRECQL5-2 using a telomeric probe. Yellow arrows indicate ends of undercondensed chromatids.
1628 Nucleic Acids Research, 2012,Vol.40, No. 4supercoils, the helicase activity of RECQL5 could be
modulated temporarily by Topoisomerase IIa to accom-
modate the decatenation activity. In an analogous
manner, previous studies indicated that Werner ATPase
activity was inhibited by Topoisomerase I (39).
RECQL5, but not WRN, can stimulate Topoisomerase
IIa mediated DNA decatenation
RecQ helicase family members WRN, BLM and
RECQL5, have been shown to interact with type I
Figure 4. RECQL5 physically interacts with Topoisomerase IIa during S-phase. (A) Western blot of whole cell lysates from HeLa shScrambled,
shRECQL5-1 and shRECQL5-2 cells, probed with indicated antibodies. Equal loading was conﬁrmed by probing with anti-Actin antibody.
(B) Immunoprecipitation of RECQL5 and (C) Topoisomerase IIa from HeLa whole cell extracts and probed with indicated antibodies.
(D) Immunoprecipitation of RECQL5 from a mixture of RECQL5 and Topoisomerase IIa recombinant proteins and probed with indicated
antibodies. (E) Representative ﬂow cytometry histograms of HeLa cells analyzed after 2mM hydroxyurea treatment and released for the time
indicated. DNA content stained with PI was plotted against cell number. (F) Confocal images of representative HeLa cells ﬁxed and stained for
RECQL5 and Topoisomerase IIa after 2mM hydroxyurea treatment and then released for the time indicated. Staining protocol is described in
‘Materials and Methods’ section. Images are pseudo colored: green-RECQL5, red-Topoisomerase IIa and blue-DAPI stain of nucleus, with yellow
areas indicating the co-localization. The co-localization channel was generated by the Volocity software. Co-localization was determined by the
following equation: (Xi  Xmean)( Yi  Ymean) where Xi is the intensity of the voxel for the Red Fluorescence Channel and Yi is the intensity of the
voxel for the Green Fluorescence channel (62). The ﬁfth panel is the merge of all three channels.
Nucleic Acids Research,2012, Vol.40, No. 4 1629topoisomerases (4,39,40). Recently, it was shown that
BLM helicase and Topoisomerase IIa interact to
maintain genomic integrity (24). Although this interaction
served to stimulate BLM helicase activity, BLM helicase
was not reported to stimulate DNA decatenation (24).
Since Werner helicase has been suggested to play a role
in DNA decatenation, nuclear extracts were prepared
from U2OS cells stably depleted of WRN and used in
the in vitro decatenation assay (41,42). Our results
indicate that WRN depletion does not inﬂuence the
DNA decatenation activity of Topoisomerase IIa in
cell extracts (Figure 6A–C). Thus stimulation of
Topoisomerase IIa decatenation activity seems to be
speciﬁc to RECQL5.
Depletion of RECQL5 increases apoptosis and activates a
G2/M checkpoint
Topoisomerase II activity is required to separate repli-
cated daughter DNA strands and a failure to do so
results in cell death (43). Similarly prolonged treatment of
cells with ICRF193 causes apoptosis, suggesting that the
cells are sensitive to the catalytic inhibition of
Topoisomerase IIa activity (43,44). We observed that
stable depletion of RECQL5 in human cells decreased
their survival in culture. In fact, most cells failed to
survive after 2 weeks of RECQL5 depletion and those
that did had reversed to normal RECQL5 levels. In
order to measure the level of apoptosis in the RECQL5
knockdowns, we stained the cells with antibodies to
annexin and performed ﬂow cytometric analysis. Our
data showed a dose-dependent increase in the percentage
of apoptotic cells in RECQL5-depleted HeLa cells. This
increase ranged from nearly 6-fold in the shRECQL5-1
to nearly 14-fold in the shRECQL5-2 silenced cells
(Figure 7A and B). Similar results were observed in
WI38 (Supplementary Figure S3A and B) suggesting
that this result was independent of cell type. Consistent
with the above data, the ratio of cleaved PARP to total
PARP was signiﬁcantly higher in the RECQL5-depleted
cells as compared to the control scrambled cells
(Figure 7C).
It has previously been reported that inhibition of
Topoisomerase IIa catalytic activity or DNA decatenation
in HeLa cells can activate a DNA damage-independent
Figure 5. RECQL5 stimulates Topoisomerase IIa catalyzed DNA decatenation. (A) Decatenation assay carried out with nuclear extracts of HeLa
shScrambled, shRECQL5-1 and shRECQL5-2 at indicated concentrations. (B) Quantiﬁcation of the decatenation was performed by measuring the
intensity of the decatenated bands. Error bars represent  SD, n=3. ***P<0.0001, f-test (C) DNA decatenation assays were carried out as
described in ‘Materials and Methods’ section using recombinant Topoisomerase IIa with recombinant RECQL5 added in increasing amounts as
indicated. K-kinetoplast DNA and C-covalently closed minicircles. (D) Quantiﬁcation of the decatenation was performed by measuring the intensity
of the decatenated bands. Error bars represent  SD, n=3. *P<0.01, Student’s t-test. (E) Helicase assay using puriﬁed RECQL5 and increasing
quantity of Topoisomerase IIa.
1630 Nucleic Acids Research, 2012,Vol.40, No. 4checkpoint (45). Although controversial, the checkpoint
has been shown to activate Chk2 and be independent of
Chk1 phosphorylation (43,44). We therefore checked the
levels of phospho-Chk2 and -Chk1 in RECQL5-depleted
cells. Our results indicated increased levels of Chk2
phosphorylated at threonine 68, but not Chk1 phospho-
rylated at serine 345 in the RECQL5-depleted cells as
compared to the scrambled controls (Figure7D). This ob-
servation was consistent with our cell cycle data where we
observed accumulation of cells in G2/M phase and the
lack of cells passing the 4N stage of the cell cycle, as the
activation of Chk2 at the G2/M phase triggers increased
apoptosis.
DISCUSSION
Based on the data presented here, we propose a model
(Figure 8) in which the interaction between RECQL5
and Topoisomerase IIa plays a putative role in resolving
torsional and replicative stress associated with termination
of replication (when the opposing replication forks
approach each other). In this model, RECQL5 helicase
could resolve the steric constraints that arise due to the
formation of positive supercoils during convergence of the
opposite replication forks on a linear chromosome. We
hypothesize that by unwinding the duplex DNA and con-
verting positive supercoils into interlocked catenates,
RECQL5 would provide access for Topoisomerase IIa,
which could then resolve the daughter strands. This
model is similar to previous models suggesting that a
helicase and a type II topoisomerase working together
could co-operate in separation of the sister strands (46).
Yeast SGS1 is proposed to interact with Topoisomerase II
in a similar manner and participate in faithful chromo-
some segregation (23).
Our work also demonstrates a ‘division of labor’ that
takes place in the overlapping functional roles of the RecQ
helicases. Mammals have evolved to have ﬁve different
RecQ helicases whereas bacteria and yeast express
one (47). Yeast SGS1 has been suggested to be a function-
al homolog of human WRN and BLM helicases (1,48,49).
By virtue of its ability to stimulate Topoisomerase
IIa-mediated decatenation, we identify RECQL5 as a
mammalian functional counterpart of SGS1. BLM and
RECQL5 have been shown to disrupt RAD51 ﬁlament
formation, and both interact with Topoisomerase
IIIa (4,14,40,50). The present study identiﬁes the inter-
action of RECQL5 and Topoisomerase IIa during repli-
cation whereas the interaction between BLM and
Topoisomerase IIa has been identiﬁed to be highest during
mitosis (24). Another distinguishing element of the BLM–
Topoisomerase IIa interaction is that Topoisomerase IIa
stimulates the helicase activity of BLM whereas BLM was
unable to stimulate the decatenation by Topoisomerase
IIa (24). This is in stark contrast to what we report here
for the RECQL5-Topoisomerase IIa interaction. It could
be possible that the two sets of interactions could follow
one another, highlighting the importance of RecQ
helicases in the maintenance of genomic integrity during
the various stages of cell cycle. In this work, we also show
that Werner does not inﬂuence Topoisomerase
IIa-mediated DNA decatenation. Therefore, the ability
to affect decatenation appears to be RECQL5 speciﬁc.
The functional demarcation is also seen among
the RecQ helicases through their interaction with
Topoisomerase IIIa. While BLM forms a part of a
multiprotein complex and is involved in the dissolution
of the sister chromatids, no such function has yet been
attributed to the RECQL5-Topoisomerase IIIa inter-
action (51–53). This could in part explain why RECQL5
and BLM have non-redundant roles in the suppression of
crossovers during replication (14).
Recql5 knockout mice display chromosomal
abnormalities including a high incidence of sister chroma-
tid exchanges (13). SCE are believed to arise as process of
recombination that occurs after double-strand breakage in
sister chromatids (54). Though RECQL5 promotes strand
exchange on DNA structures that mimic stalled forks, it
Figure 6. RECQL5, but not WRN, can stimulate Topoisomerase IIa mediated DNA decatenation. (A) Western blot showing reduced expression of
WRN in nuclear extracts of U2OS shWRN cells compared to control shScrambled cells. Equal loading was conﬁrmed by probing with a Lamin A
speciﬁc antibody. (B) Decatenation assay carried out with the nuclear extracts of U2OS shScrambled and shWRN at indicated concentrations.
(C) Quantiﬁcation of the decatenation was performed by measuring the intensity of the decatenated bands. Error bars represent  SD, n=3.
Nucleic Acids Research,2012, Vol.40, No. 4 1631Figure 7. Depletion of RECQL5 increases apoptosis and activates a G2/M checkpoint. (A) Dot plots of FITC-Annexin versus PI two parameter
ﬂow cytometry of HeLa shScrambled, shRECQL5-1 and shRECQL5-2 cells. (B) Quantiﬁcation of Annexin positive and PI negative cells in HeLa.
Error bars represent  SD, n=2; *P=0.02, **P=0.002, Student’s t-test. (C and D) Western blot of whole cell lysates from HeLa shScrambled,
shRECQL5-1 and shRECQL5-2 cells probed with indicated antibodies.
Figure 8. Model to demonstrate the interaction of RECQL5 and Topoisomerase IIa. Model to demonstrate the interaction of RECQL5 and
Topoisomerase IIa functioning to separate daughter chromatids at the end of replication. RECQL5 serves to unwind the parental DNA at the
converging replication forks with Topoisomerase IIa behind functioning to decatenate newly formed daughter molecules. The helicase activity is then
inhibited till Topoisomerase II performs the decatenation.
1632 Nucleic Acids Research, 2012,Vol.40, No. 4has been suggested that the frequency of SCE depends on
the size of the replicon rather than stalling of replication
forks (9,55). Previous reports also suggest that recombina-
tional processes take place in generation of SCEs which
could involve the participation of type II topoisomerase
(55,56). Indeed, inhibition of Topoisomerase II by
ICRF-193 has been demonstrated to increase SCE levels
(57). In the absence of RECQL5, it is quite possible that
an impaired Topoisomerase IIa bound to DNA could be
converted to double strand breaks. This could explain in
part the accumulation of H2AX foci observed when
RECQL5 is depleted in cells (13); in turn, this could
lead to formation of tumors as observed in Recql5
knockout mice (13).
RecQ5 loss in Drosophila causes mitotic defects and
more recently was found to induce the formation of
anaphase bridges in syncytial embryos (15,16). The role
of Topoisomerase IIa in the formation of anaphase
bridges is well documented (58). It is therefore likely
that a decreased interaction between RECQL5 and
Topoisomerase IIa could contribute to the formation of
anaphase bridges (59). Moreover, previous work has also
demonstrated the link between Topoisomerase IIa activity
in the separation of telomeric ends at late S-phase and the
occurrence of mitotic abnormalities similar to those
described here (60,61). We also observed the interaction
of RECQL5 and Topoisomerase IIa during mid-late
S-phase and have documented mitotic abnormalities as a
consequence of RECQL5 knockdown. The differences in
the length of the telomeric ends in mice and humans could
perhaps explain why the Recql5 knockout mice do not
display the phenotypes we have observed.
In conclusion, this study identiﬁes a novel physical and
functional interaction between human RECQL5 and
Topoisomerase IIa. This interaction is likely to be an
important mechanism by which RECQL5 and
Topoisomerase IIa coordinately enhance the stability of
eukaryotic chromosomes.
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